Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Based on its recent analysis of the North American digital health market, Frost & Sullivan recognizes Lumeon with the 2021 North […]
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the […]
BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio
BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products […]
AI Breakthrough for Faster, Cheaper and Injection-free Heart Scans
New artificial intelligence (AI) technology could lead to the next generation of heart MRI scans […]
BioNTech Plans Malaria Vaccine Based on Revolutionary Covid-19 Jab Technology
BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the launch of its Malaria project, which aims to […]
The Biotech Market: Why Investors Should Take Interest
As the biotech industry continues to reach new heights, Maxim Manturov, Head of Investment Research at Freedom Finance […]
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi Research
Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small […]
World-renowned Urologist Professor Prokar Dasgupta Joins MysteryVibe as Chief Medical Officer
MysteryVibe announces the strategic hire of Professor Prokar Dasgupta as their new Chief Medical Officer (CMO), to support the development […]
ZOLL Announces Approval of Next-Generation Remedē System for the Treatment of Central Sleep Apnea
ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more